DBD
Diebold Nixdorf·NYSE
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-22
Latest data update time: Updated on 2026-03-22
6.77 / 10Overall Score
OutperformInvestment Rating
6.77 / 10Overall Score
OutperformInvestment Rating
Is DBD a Good Buy Right Now?
- Based on a composite score of 6.77/10, we rate DBD as a Outperform. Our analysis breaks down into 5.69/10 for Fundamentals, 7.52/10 for Technicals, and 6.94/10 for Sentiment, indicating the stock is likely to See further upside.
Technical Analysis of DBD?
Is DBD undervalued or overvalued?
Is money flowing into or out of DBD?
Is DBD a Good Buy Right Now?
- Based on a composite score of 6.77/10, we rate DBD as a Outperform. Our analysis breaks down into 5.69/10 for Fundamentals, 7.52/10 for Technicals, and 6.94/10 for Sentiment, indicating the stock is likely to See further upside.
Is DBD undervalued or overvalued?
Technical Analysis of DBD?
Is money flowing into or out of DBD?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
